Targeting Ocular Disorders
With its complex structure and the breadth of ocular disorders, the eye presents unique challenges to drug discovery. Cambridge Healthtech Institute’s fourth annual Targeting Ocular Disorders conference provides a platform to discuss novel targets and disease pathways, the latest drug delivery methods, and the most promising emerging therapies. A special focus will be on gene therapy, stem cell therapies, and treatments outside of the well-established anti-VEGF therapies. The event will cover a broad range of diseases including but not limited to glaucoma, wet and dry age‐related and diabetic macular degeneration, retinopathy and retinitis pigmentosa.
Trial Runners, the CRO you trust, is shipping up to Boston to attend the CHI sponsored Discovery on Target Convention. More specifically, we will be attending the program therein called Targeting Ocular Disorders. We look forward to seeing you in Boston!
The Ophthalmology Innovation Summit was created to facilitate meaningful interactions and business partnerships between physicians, entrepreneurs, investors, and industry executives who are driving ophthalmic innovation. OIS addresses key issues – both hurdles and opportunities – while showcasing the most promising private ophthalmic companies.
In downtown Chicago, OIS is holding another summit in conjunction with the American Academy of Ophthalmology’s annual convention. Trial Runners is excited to announce that we will be attending the OIS session, and also exhibiting there. Come see our table in the exhibition hall!
Trial Runners is looking forward to attending these great events for the Fall season and look forward to an eventful 2017!